Diazepam News and Research

RSS
Diazepam is a drug used to treat mild to moderate anxiety and tension and to relax muscles. It is a type of benzodiazepine. Also called Valium.
Finding may pave way for much-needed treatments for people with epilepsy

Finding may pave way for much-needed treatments for people with epilepsy

Veterans who died from drug overdoses also prescribed benzodiazepines for pain

Veterans who died from drug overdoses also prescribed benzodiazepines for pain

Possible therapies to address cognitive symptoms in individuals with schizophrenia

Possible therapies to address cognitive symptoms in individuals with schizophrenia

Alexza begins Phase 2a study of AZ-002 for ARS-related epilepsy management

Alexza begins Phase 2a study of AZ-002 for ARS-related epilepsy management

Almost 42% of US drinkers use alcohol-interactive prescription medications, study finds

Almost 42% of US drinkers use alcohol-interactive prescription medications, study finds

Scientists unravel neural circuit that could play important role in autism

Scientists unravel neural circuit that could play important role in autism

2 medications equally effective in treating major epileptic brain seizures in children

2 medications equally effective in treating major epileptic brain seizures in children

Study: Lorazepam drug not effective in treating pediatric status epilepticus

Study: Lorazepam drug not effective in treating pediatric status epilepticus

Acorda gets FDA Complete Response Letter for PLUMIAZ Nasal Spray NDA

Acorda gets FDA Complete Response Letter for PLUMIAZ Nasal Spray NDA

Two sedative drugs effectively treat prolonged seizures in children

Two sedative drugs effectively treat prolonged seizures in children

FDA approves Lannett's ANDA for Diazepam Oral Solution

FDA approves Lannett's ANDA for Diazepam Oral Solution

New study shows anti-anxiety drugs and sleeping pills associated with increased risk of death

New study shows anti-anxiety drugs and sleeping pills associated with increased risk of death

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Research data on AMPYRA Extended Release Tablets to be presented at CMSC and ACTRIMS meeting

Research data on AMPYRA Extended Release Tablets to be presented at CMSC and ACTRIMS meeting

Phase 1 clinical study of rHIgM22 initiated for treatment of multiple sclerosis

Phase 1 clinical study of rHIgM22 initiated for treatment of multiple sclerosis

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Acorda Therapeutics acquires Neuronex

Acorda Therapeutics acquires Neuronex

Bumetanide could treat children with severe autism or Asperger's syndrome

Bumetanide could treat children with severe autism or Asperger's syndrome

Benzodiazepines associated with fatal pneumonia

Benzodiazepines associated with fatal pneumonia